|
 |
BIT's upcoming events |
|
|
|
|
|
WSA-2008
(July 20-26, 2008, Kunming, China) |
|
|
|
|
|
CEMD-2008
(Oct.22-28, 2008, Beijing & Xi'an, China) |
|
|
|
|
|
WCG 2008
(Dec. 5-7, 2008, Guangzhou, China) |
|
|
|
|
|
|
|
| |
Track 3: Bioprocess for pharmaceuticals |
-Improving Accessibilities of Challenging Therapeutics |
|
The rapidly developing biologics industry is faced with many complex areas of concern. There are multiple issues that need to be analyzed as we explore process standardization, and the financial and economic ramifications of new systems and methodologies. Join us at this inaugural event as we explore the strategic issues around building biologics into your portfolio. Attendees of this important conference will have the opportunity to view the latest technologies in the exhibit hall, attend other sessions that are of interest to them, network through roundtable discussions with the larger audience, and take part in thought provoking keynote presentations from industry leaders. |
| |
| Session 11 Impact of Genomics and Systems Biology on Pharmic Biotechnology |
| This session will cover the following potential topics: |
| |
| |
| |
Increasing Productivities of Fermentation Processes by Genomics Tools
Yeast Fermentation
Fungal Fermentation
Fermentation with Lactic Acid Bacteria
Biocatalysis Screening using Genomics Tools
|
| Or you can propose new topics to be covered from your expert opinion here! |
| |
| Session 12 Productive Bioprocesses for Productions of Chiral Chemicals and Small Molecule Drugs |
| This session will cover the following potential topics: |
| |
| |
| |
New Biosynthesis for Chiral Chemicals and Small Molecule Drugs
Highly Efficient Bioprocesses of Chiral Drugs
Biocatalysts for Synthesis of Chiral Pharmaceutical Intermediates
Application of Enzymatic Asymmetric Catalytic Technology in Synthesis of Chiral Drugs
Advance in Production of Antibodies to Small Molecule Haptenes
Bioprocesses for Prepare Long Chain Polypeptide
Bioprocesses for Macrocyclic Peptides
Fermentation Methods for Preparation of Therapeutic Natural Products
|
| Or you can propose new topics to be covered from your expert opinion here! |
| |
| Session 13 Advances of Bioprocesses Development for Protein Drugs, Vaccines and Mono-clone Antibodies |
| This session will cover the following potential topics: |
| |
| |
| |
Progress in Synthetic Methodology for Protein Drug
Protein/Peptide Biomarker Discovery
Basic Protein Biochemistry
Single Cell Eukaryotic Based Protein Synthesis
Protein Cross Linking
Bioreactors for Synthesis of Proteins
Protein/ Peptide Vaccine Antigen Selection & Design
Bioprocesses for Nucleic Acid Vaccines
Human Antibodies & Hybridomas
Plant-Based Vaccines & Antibodies
Modern Vaccines Adjuvants & Delivery Systems
Modern Mucosal Vaccines, Adjuvants & Microbicides
Hybridomas and at the Production of Monoclonal Antibodies
Protein G Based Isolation of Monoclonal Antibody
Key Regulatory Issues with Monoclonal and Vaccine Production Biological Safety: The Case Studies of Vaccines and Mono-clone Antibodies
|
| Or you can propose new topics to be covered from your expert opinion here! |
| |
| Session 14 Progress on Bioprocesses of Cell Therapeutics |
| This session will cover the following potential topics: |
| |
| |
| |
Stem Cell Therapies
Umbilical Cord Blood Stem Cell Transplant
Organ Transplantation Combined with Cell Therapy
Basic Technologies for Cell Therapy
Sources of Cells for Therapy
Types of Cells Available for Therapy
Flow Cytometry and Cell Sorting Technologies
Cell Separation Techniques & Preservation Technology
Density-Based Isolation Methods
Selective Expansion of T Cells for Immunotherapy
Delivery Systems for Cell Therapy
Devices for Delivery of Cell Therapy
Quality Control and Safety
|
| Or you can propose new topics to be covered from your expert opinion here! |
| |
| Session 15 Upstream Gene Therapeutics Process Development: Anti-sense, siRNA, RNAi and Gene Therapy Drugs |
| This session will cover the following potential topics: |
| |
| |
| |
Upstream Research on Functional Genomic and Drug Discovery Applications of Anti-sense,siRNA,RNAi and Gene Therapy Drugs
The Process of Gene Expression
How Anti-sense Controls Gene Expression
The Original Anti-sense Compounds
The Importance of Rigorous siRNA Design
The Development of siRNA Modifications
Specificity of Gene Silencing
RNAi Mechanism & Approaches
Screening Approaches for RNAi Therapeutics
Delivery Methods of RNA Based Drugs
Off-target Effects
Patents & Principle in Gene Therapy
Gene Therapy in Severe Diseases
Delivery Mechanism in Gene Therapy
Market Drivers and Restraints |
| Or you can propose new topics to be covered from your expert opinion here! |
| |
|
|
